The Tunisia Pharmaceutical Market was USD 2.15 Bn in 2023 and is expected to expand at a compound annual growth rate (CAGR) of 12.9 % from 2023 to 2030, reaching USD 5.03 Bn by 2030, reported openPR.
Tunisia has been making investments to upgrade its medical facilities, including building new clinics, hospitals, and clinics.
The Tunisian government has implemented measures to boost the pharmaceutical sector and increase access to medications, it added.
As the public and private sectors concentrate on enhancing health outcomes, Tunisia’s healthcare costs have been gradually increasing.
The market for antiviral medications in Tunisia is projected to increase at a 5.4% annual pace between 2023 and 2030, reaching USD 10.36 million by that time.
By product, the pharmaceutical market in Tunisia is dominated by prescription medications.
This drug includes pharmaceuticals for the cardiovascular, neurological disorders, cancer, and antibiotics.
Over-the-counter (OTC) pharmaceuticals are prescription-free medications that are frequently used for preventative care or moderate medical issues, according to the same source.
